Diabetes control and complications: the role of glycated haemoglobin, 25 years on. (Q35812833)

10 August 2017

1 reference

title

Diabetes control and complications: the role of glycated haemoglobin, 25 years on. (English)

1 reference

10 August 2017

Jeffcoate SL

1 reference

10 August 2017

publication date

1 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

657-665

1 reference

Complexity science: The challenge of complexity in health care

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Complexity, leadership, and management in healthcare organisations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Complexity science: complexity and clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

US public health and the 21st century: diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Effect of improved glycemic control on health care costs and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

An economic model of the long-term health care burden of Type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Lessons from the glitazones: a story of drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Potential new treatments for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Glycated haemoglobin analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Lilly Lecture 1993. Glycation and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Fructosamine 3-kinase is involved in an intracellular deglycation pathway in human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Approved IFCC reference method for the measurement of HbA1c in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Clinical pathology accreditation: standards for the medical laboratory

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Standardization of HbA1c measurements--a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Survey and assessment of the actual state of routine measurement of glycohaemoglobin/GHb by commercial methods: warning to the users and the providers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Factors influencing glycemic control in young people with type 1 diabetes in Scotland: a population-based study (DIABAUD2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Investigation of the mechanism underlying the variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Is HbA1 Measurement Superfluous in NIDDM?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Postprandial blood glucose. American Diabetes Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

What is the real contribution of fasting plasma glucose and postprandial glucose in predicting HbA(1c) and overall blood glucose control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Nonfasting Plasma Glucose is a Better Marker of Diabetic Control Than Fasting Plasma Glucose in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

What's ahead in glucose monitoring? New techniques hold promise for improved ease and accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Glycaemic control and reticulocyte count in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

A falling HbA1c is not necessarily an indicator of improving diabetes control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

New diagnostic criteria for diabetes--are they doing what they should?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

IGT and IFG. Time for revision?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

ABC of arterial and venous disease: vascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Role of hyperglycemia in nitrotyrosine postprandial generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Coping with complexity: educating for capability

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Adoption of disease management model for diabetes in region of Maastricht.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Disease management: has it a future? It has a compelling logic, but needs to be tested in practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

The impact of blood glucose self-monitoring on metabolic control and quality of life in type 2 diabetic patients: an urgent need for better educational strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Management of diabetes: are doctors framing the benefits from the wrong perspective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-5491.2003.01065.X

Glycosylation of plasma protein and its relation to glycosylated hemoglobin in diabetes

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIAB.29.4.296

Identifiers

DOI

10.1046/J.1464-5491.2003.01065.X

1 reference

10 August 2017

1 reference